Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.

21
Strong Sell
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000735
CNY
29.07
0.37 (1.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
1,312.00
1,462.00
1,459.00
1,504.00
1,102.00
1,956.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,312.00
1,462.00
1,459.00
1,504.00
1,102.00
1,956.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
134.00
134.00
142.00
149.00
148.00
152.00
Operating Expenses
82.00
83.00
88.00
97.00
123.00
49.00
General and Administration Expenses
759.00
881.00
893.00
951.00
1,148.00
1,475.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,171.00
1,337.00
1,341.00
1,395.00
1,450.00
1,912.00
Operating Profit (PBDIT) excl Other Income
141.00
125.00
117.00
108.00
-348.00
43.00
Other Income
12.00
17.00
20.00
42.00
145.00
70.00
Operating Profit (PBDIT)
214.00
216.00
209.00
229.00
-139.00
180.00
Interest
82.00
83.00
88.00
97.00
123.00
49.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
67.00
75.00
71.00
70.00
69.00
69.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
65.00
58.00
49.00
61.00
-347.00
-2,009.00
Provision for Tax
11.00
11.00
20.00
25.00
4.00
30.00
Profit After Tax
56.00
43.00
30.00
35.00
-359.00
-2,041.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.06
0.05
0.03
0.04
-0.37
-2.11
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -10.26% vs 0.24% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 12.58% vs 7.23% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -1.28% vs -5.73% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 28.46% vs 45.71% in Dec 2023

Compare Profit and Loss Results of Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
1,312.00
0
1,312.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
1,312.00
0
1,312.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
134.00
0
134.00
0%
Operating Expenses
82.00
0
82.00
0%
General and Administration Expenses
759.00
0
759.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
1,171.00
0
1,171.00
0%
Operating Profit (PBDIT) excl Other Income
141.00
0.00
141.00
0%
Other Income
12.00
0
12.00
0%
Operating Profit (PBDIT)
214.00
0
214.00
0%
Interest
82.00
0
82.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
67.00
0
67.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
65.00
0
65.00
0%
Provision for Tax
11.00
0
11.00
0%
Profit After Tax
56.00
0
56.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.0584
0
0.06
0%
Profit And Loss - Net Sales
Net Sales 1,312.66 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -10.26% vs 0.24% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 141.47 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 12.58% vs 7.23% in Dec 2023

Profit And Loss - Interest
Interest 82.78 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -1.28% vs -5.73% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 56.44 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 28.46% vs 45.71% in Dec 2023